Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11390611 Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Deciphera Pharmaceuticals

Current Assignee

Deciphera Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

July 19, 2022

Patent Application Number

16870418

Date Filed

May 8, 2020

Patent Citations

US Patent 10329270 Heteroaryl compounds as BTK inhibitors and uses thereof

US Patent 10010548 2,4-disubstituted pyrimidines useful as kinase inhibitors

US Patent 10259826 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

US Patent 10273242 Compound inhibiting activities of BTK and/or JAK3 kinases

US Patent 10316002 Kinase inhibitors for the treatment of disease

US Patent 10336734 Inhibitors of ACK1/TNK2 tyrosine kinase

Patent Primary Examiner

CPC Code

...

Described herein are compounds that are inhibitors of autophagy and their use in the treatment of disorders such as cancers.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11390611 Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool